Frontal Alpha Asymmetry and Pediatric Emergence Delirium
Launched by GANGNAM SEVERANCE HOSPITAL · Mar 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how preoperative anxiety in young children affects a condition called emergence delirium, which can occur after they wake up from anesthesia. Researchers are particularly interested in a brain activity pattern called EEG frontal alpha asymmetry, which they believe might help explain how anxiety before surgery contributes to emergence delirium in kids undergoing eye surgery. To understand this better, they will measure children's anxiety levels before surgery and their brain activity, as well as assess how they feel when they wake up.
The trial is looking for children aged 2 to 8 years old who are in good health (physical status I-II) and scheduled for certain eye surgeries that need general anesthesia. However, children with developmental delays, neurological or psychiatric conditions, or those who have had recent anesthesia are not eligible to participate. If eligible, participants can expect to complete some anxiety assessments and have their brain activity monitored to help researchers learn more about the relationship between anxiety and emergence delirium. This research could lead to better ways to manage anxiety in young patients and improve their recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 2-8 year
- • Children with an American Society of Anesthesiologists (ASA) physical status of I-II
- • Children who are scheduled to undergo elective ophthalmological requiring general anesthesia
- Exclusion Criteria:
- • Emergency surgery
- • Patients with developmental delays
- • Patients with neurological or psychiatric diseases associated with symptoms of agitation, anxiety, attention deficit, sleep disturbances
- • Patients with autism
- • Patients with a recent history (within one month) of receiving general anesthesia
- • Patients with congenital or genetic diseases that may influence brain development
About Gangnam Severance Hospital
Gangnam Severance Hospital is a renowned medical institution located in Seoul, South Korea, dedicated to advancing healthcare through innovative research and clinical excellence. As a leading clinical trial sponsor, the hospital is committed to conducting cutting-edge research that enhances patient care and contributes to medical knowledge across various specialties. With a state-of-the-art facility and a multidisciplinary team of experienced researchers and healthcare professionals, Gangnam Severance Hospital prioritizes patient safety and ethical standards while striving to develop new treatments and therapies that address unmet medical needs. Through collaboration with academic institutions and industry partners, the hospital plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Young Song
Principal Investigator
Gangnam Severance Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials